ResMed/$RMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ResMed
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Ticker
$RMD
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
9,980
ISIN
US7611521078
Website
ResMed Metrics
BasicAdvanced
$37B
28.05
$8.91
0.76
$2.07
0.85%
Price and volume
Market cap
$37B
Beta
0.76
52-week high
$263.05
52-week low
$179.42
Average daily volume
984K
Dividend rate
$2.07
Financial strength
Current ratio
3.411
Quick ratio
2.058
Long term debt to equity
14.445
Total debt to equity
15.142
Dividend payout ratio (TTM)
23.14%
Interest coverage (TTM)
139.28%
Management effectiveness
Return on assets (TTM)
14.01%
Return on equity (TTM)
25.81%
Valuation
Price to earnings (TTM)
28.052
Price to revenue (TTM)
7.308
Price to book
6.61
Price to tangible book (TTM)
16.16
Price to free cash flow (TTM)
23.528
Dividend yield (TTM)
0.83%
Forward dividend yield
0.85%
Growth
Revenue change (TTM)
9.54%
Earnings per share change (TTM)
37.08%
3-year revenue growth (CAGR)
12.37%
3-year earnings per share growth (CAGR)
18.91%
3-year dividend per share growth (CAGR)
7.21%
What the Analysts think about ResMed
Analyst ratings (Buy, Hold, Sell) for ResMed stock.
ResMed Financial Performance
Revenues and expenses
ResMed Earnings Performance
Company profitability
ResMed News
AllArticlesVideos
Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
GlobeNewsWire·3 weeks ago
Resmed Acquires VirtuOx
GlobeNewsWire·1 month ago
ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast
Benzinga·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jun12
ResMed
Dividend·Payment
$0.53Per share
FAQs
What’s the current market cap for ResMed stock?
ResMed (RMD) has a market cap of $37B as of June 06, 2025.
What is the P/E ratio for ResMed stock?
The price to earnings (P/E) ratio for ResMed (RMD) stock is 28.05 as of June 06, 2025.
Does ResMed stock pay dividends?
Yes, the ResMed (RMD) stock pays dividends to shareholders. As of June 06, 2025, the dividend rate is $2.07 and the yield is 0.85%. ResMed has a payout ratio of 23.14% on a trailing twelve-month basis.
When is the next ResMed dividend payment date?
The next ResMed (RMD) dividend payment is scheduled for June 12, 2025.
What is the beta indicator for ResMed?
ResMed (RMD) has a beta rating of 0.76. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.